Zynerba Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ZYNE Zynerba Pharmaceuticals Inc
FUN Cedar Fair LP
BAC Bank of America Corp
XLF Financial Select Sector SPDR® Fund
FRAN Francesca's Holdings Corp
ED Consolidated Edison Inc
BIIB Biogen Inc
CNF CNFinance Holdings Ltd
LVS Las Vegas Sands Corp
AZDDQ Azure Dynamics Corp

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which is a non-psychoactive cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. ZYN002 is in Phase II clinical development in patients with refractory epilepsy, in patients with osteoarthritis of the knee, as well as in patients with Fragile X syndrome. ZYN001 is a pro-drug of tetrahydrocannabinol (THC) that enables transdermal delivery through the skin and into the circulatory system through a patch. ZYN001 is targeting two pain indications, fibromyalgia and peripheral neuropathic pain.

Closing Price
Day's Change
-0.205 (-5.53%)
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    3:59p ET 07/02/20
  • Last (size)
  • 52-Wk Range
    2.55 - 15.70
  • (07/05/19 - 03/17/20)
  • 106.0%
  • Market Cap
  • Shares Outstanding
  • -1.58
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 3.1
  • 37.96
  • (% of float 06/15/20)

Latest News

July 01, 2020
9:31 am ET
PR Newswire
June 30, 2020
10:45 am ET
PR Newswire
6:46 am ET
Globe Newswire
June 22, 2020
9:00 am ET
PR Newswire
June 15, 2020
9:00 am ET
PR Newswire
June 03, 2020
9:00 am ET
PR Newswire
May 26, 2020
6:52 am ET
Globe Newswire
6:50 am ET
Globe Newswire
May 22, 2020
7:30 am ET
Globe Newswire
May 21, 2020
9:00 am ET
PR Newswire
8:00 am ET
Globe Newswire
May 11, 2020
6:50 am ET
Globe Newswire
May 07, 2020
9:00 am ET
PR Newswire
April 10, 2020
8:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.